samedan logo
 
 
spacer
home > pmps > spring 2004 > chris tierney, clinical trials development manager of exel's health care sector, gives an indepth review of clinical trials logistics ?° creating value in the clinical supplies chain
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Chris Tierney, Clinical Trials Development Manager of Exel's Health Care Sector, gives an indepth review of Clinical Trials Logistics ?° Creating Value in the Clinical Supplies Chain

Clinical trials are becoming increasingly global in nature and more complex in protocol design. They are being driven by larger patient numbers to satisfy regulatory standards, successful co-ordination of patient screening, enrolment, randomisation and study-drug distribution. These drivers result in the pharmaceutical industry facing more challenging inventory management issues than ever before. In response, pharmaceutical companies are seeking innovative methods of enhancing supply chain efficiency and are increasingly looking to clinical trials logistics (CTL) - the delivery of investigational medicinal products to investigator sites - as a strategic key to unlocking significant value in the R&D process through accelerating the rate new products get to market.

This article reviews the role of supply chain in clinical trials, drawing on the key findings of recent market research that highlight future trends in service requirements, and points to the development of CTL and the core skills and expertise pharmaceutical companies seek when looking for a supplies management partner.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
5
     

There are no comments in regards to this article.

spacer
By Chris Tierney, Clinical Trials Development Manager of Exel's Health Care Sector

Chris Tierney joined Exel in 1997 as part of the company's international graduate management training scheme. Following line management roles in operations and, more recently, marketing and business development, Chris now has key responsibility for the development of the clinical trials logistics solution within Exel's health care sector. Chris holds a BSc (Hons) in Medical Biochemistry from the University of Leicester and an MBA from the School of Management at Bradford University.
spacer
Chris Tierney
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Syntegon and Vetter win PDA Drug Delivery Innovation Award for Versynta microBatch

Waiblingen/Germany, October 6, 2021. Together with Vetter, an international pharmaceutical service provider for injectables, Syntegon (formerly Bosch Packaging Technology) has won the PDA Drug Delivery Innovation Award. In the "Partnership Innovation" category, the Parental Drug Association (PDA) honors development projects by pharmaceutical and machine manufacturers that advance the production of (bio)pharmaceuticals. The collaboration between Vetter and Syntegon resulted in Versynta microBatch, a highly flexible and fully automated production cell with a gloveless isolator, the smallest possible dimensions and a complete batch-to-batch changeover of less than two hours.
More info >>

White Papers

Nasal Drug Delivery with a Focus on Chronic Rhino-Sinusitis

Aptar Pharma

Aptar Pharma have hosted a scientific roundtable on “Nasal drug delivery with a focus on chronic rhino‑sinusitis”. This international scientific forum was held in Paris, France on November 13th 2012. The roundtable was organized to explore and exchange views on the science of various forms of sinusitis and its related unmet medical needs.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement